Vraylar (cariprazine). Silver Spring; 2015 Sep. Report No.: 3821760. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/204370Orig1Orig2s000Approv.pdf. Accessed 22 Aug 2024.

European Medical Agency. Reagila: EPAR—Summary for the public. 2017. Report No.: EMA/339882/2017. https://www.ema.europa.eu/en/documents/overview/reagila-epar-summary-public_en.pdf. Accessed 22 Aug 2024.

Vraylar (cariprazine). Silver Spring; 2022 Dec. Report No.: 5095981. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204370s009lbl.pdf. Accessed 22 Aug 2024.

Corponi F, Serretti A, Montgomery S, Fabbri C. Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials. Int Clin Psychopharmacol. 2017;32:309–18.

Article  PubMed  Google Scholar 

Zhao M-J, Qin B, Wang J-B, Zhang Y-P, Zhao J-T, Mao Y-G, et al. Efficacy and acceptability of Cariprazine in acute exacerbation of schizophrenia: meta-analysis of randomized placebo-controlled trials. J Clin Psychopharmacol. 2018;38:55–9.

Article  CAS  PubMed  Google Scholar 

Wang Y, Xu Y, Wu P, Zhou Y, Zhang H, Li Z, et al. Exploring the interplay between core and mood symptoms in schizophrenia: a network analysis. Schizophr Res. 2024;269:28–35.

Article  PubMed  Google Scholar 

Pavlova B, Perlis RH, Alda M, Uher R. Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2:710–7.

Article  PubMed  Google Scholar 

Pinto JV, Saraf G, Vigo D, Keramatian K, Chakrabarty T, Yatham LN. Cariprazine in the treatment of bipolar disorder: a systematic review and meta-analysis. Bipolar Disord. 2020;22:360–71.

Article  CAS  PubMed  Google Scholar 

Cooper H, Mishriky R, Reyad AA. Efficacy and safety of cariprazine in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials. Psychiatr Danub. 2020;32:36–45.

Article  CAS  PubMed  Google Scholar 

Stanghellini G, Broome M, Fernandez AV, Fusar-Poli P, Raballo A, Rosfort R, et al editors. The oxford handbook of phenomenological psychopathology. Oxford: Oxford University Press; 2019.

Google Scholar 

DeRosse P, Karlsgodt KH. Examining the psychosis continuum. Curr Behav Neurosci Rep. 2015;2:80–9.

Article  PubMed  PubMed Central  Google Scholar 

Merola GP, Tarchi L, Saccaro LF, Delavari F, Piguet C, Van De Ville D, et al. Transdiagnostic markers across the psychosis continuum: a systematic review and meta-analysis of resting state fMRI studies. Front Psychiatry. 2024. https://doi.org/10.3389/fpsyt.2024.1378439.

Article  PubMed  PubMed Central  Google Scholar 

Consoli A, Brunelle J, Bodeau N, Louët E, Deniau E, Perisse D, et al. Diagnostic transition towards schizophrenia in adolescents with severe bipolar disorder type I: an 8-year follow-up study. Schizophr Res. 2014;159:284–91.

Article  PubMed  Google Scholar 

Cardno AG, Owen MJ. Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull. 2014;40:504–15.

Article  PubMed  PubMed Central  Google Scholar 

Ihler HM, Lyngstad SH, Mørch-Johnsen LE, Lagerberg TV, Melle I, Romm KL. A transdiagnostic approach to negative symptoms: exploring factor structure and negative symptoms in bipolar disorders. Front Psychiatry. 2023. https://doi.org/10.3389/fpsyt.2023.1136097.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. Cochrane Handb Syst Rev Interv. New York: Wiley; 2019. p. 143–76.

Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.

Article  PubMed  Google Scholar 

Fernández-Castilla B, Jamshidi L, Declercq L, Beretvas SN, Onghena P, Van den Noortgate W. The application of meta-analytic (multi-level) models with multiple random effects: a systematic review. Behav Res Methods. 2020;52:2031–52.

Article  PubMed  Google Scholar 

Gooty J, Banks GC, Loignon AC, Tonidandel S, Williams CE. Meta-analyses as a multi-level model. Organ Res Methods. 2021;24:389–411.

Article  Google Scholar 

Van den Noortgate W, López-López JA, Marín-Martínez F, Sánchez-Meca J. Three-level meta-analysis of dependent effect sizes. Behav Res Methods. 2013;45:576–94.

Article  PubMed  Google Scholar 

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

Article  PubMed  PubMed Central  Google Scholar 

Riley RD, Gates S, Neilson J, Alfirevic Z. Statistical methods can be improved within Cochrane pregnancy and childbirth reviews. J Clin Epidemiol. 2011;64:608–18.

Article  PubMed  Google Scholar 

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaimani A, Caldwell DM, Li T, Higgins JP, Salanti G. Undertaking network meta-analyses. Cochrane Handb Syst Rev Interv. New York: Wiley; 2019. p. 285–320.

Google Scholar 

Rücker G, Schwarzer G. Resolve conflicting rankings of outcomes in network meta-analysis: partial ordering of treatments. Res Synth Methods. 2017;8:526–36.

Article  PubMed  Google Scholar 

Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163–71.

Article  PubMed  Google Scholar 

R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2024. https://www.R-project.org.

RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio, PBC; 2024. http://www.rstudio.com/.

Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153–60.

Article  PubMed  PubMed Central  Google Scholar 

Balduzzi S, Rücker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O, et al. netmeta: an R package for network meta-analysis using frequentist methods. J Stat Softw. 2023. https://doi.org/10.18637/jss.v106.i02.

Article  Google Scholar 

Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010. https://doi.org/10.18637/jss.v036.i03.

Article  Google Scholar 

Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022;18: e1230.

Article  PubMed  PubMed Central  Google Scholar 

Wickham H, Averick M, Bryan J, Chang W, McGowan LD, François R, et al. Welcome to the tidyverse. J Open Sour Softw. 2019;4:1686.

Article  Google Scholar 

Earley WR, Burgess MV, Khan B, Rekeda L, Suppes T, Tohen M, et al. Efficacy and safety of cariprazine in bipolar I depression: a double-blind, placebo-controlled phase 3 study. Bipolar Disord. 2020;22:372–84.

Article  CAS  PubMed  Google Scholar 

Earley WR, Burgess M, Rekeda L, Hankinson A, McIntyre RS, Suppes T, et al. A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression. J Affect Disord. 2020;263:386–95.

Article  CAS  PubMed  Google Scholar 

Earley W, Burgess MV, Rekeda L, Dickinson R, Szatmári B, Németh G, et al. Cariprazine treatment of bipolar depression: a randomized double-blind placebo-controlled phase 3 study. Am J Psychiatry. 2019;176:439–48.

Article  PubMed  Google Scholar 

Durgam S, Cutler AJ, Lu K, Migliore R, Ruth A, Laszlovszky I, et al. Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial. J Clin Psychiatry. 2015;76:e1574-1582.

Article  PubMed  Google Scholar 

Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, et al. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Bipolar Disord. 2015;17:63–75.